Atea Pharmaceuticals, Inc. (AVIR) — SC 13G/A Filings
All SC 13G/A filings from Atea Pharmaceuticals, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
- SC 13G/A Filing — Feb 13, 2024
-
FMR LLC & Abigail Johnson Trim Atea Pharma Stake to 6.412%
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Atea Pharmaceuticals, Inc. (ATEA). As of De -
BML Investment Partners Amends Atea Pharma Stake, Forms Group
— Feb 7, 2024
BML Investment Partners, L.P. filed an amended Schedule 13G/A on February 7, 2024, disclosing its ownership of Atea Pharmaceuticals, Inc. common stock as of Dec -
BlackRock Updates Passive Stake in Atea Pharmaceuticals
— Jan 24, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership in Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) as of December 31, 202
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX